126 related articles for article (PubMed ID: 32258818)
1. Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach.
Snider SH; Flume PA; Gentilin SL; Lesch WA; Sampson RR; Sonne SC
Contemp Clin Trials Commun; 2020 Jun; 18():100557. PubMed ID: 32258818
[TBL] [Abstract][Full Text] [Related]
2. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
[TBL] [Abstract][Full Text] [Related]
5. Creating a Program to Support Registering and Reporting Clinical Trials at Johns Hopkins University.
Keyes A; Mayo-Wilson E; Nuamah P; Lalji A; Tetteh O; Ford DE
Acad Med; 2021 Apr; 96(4):529-533. PubMed ID: 33060401
[TBL] [Abstract][Full Text] [Related]
6. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
[TBL] [Abstract][Full Text] [Related]
7. Compliance with results reporting at ClinicalTrials.gov.
Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
[TBL] [Abstract][Full Text] [Related]
8. Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA.
Swanson MJ; Johnston JL; Ross JS
Trials; 2021 Nov; 22(1):817. PubMed ID: 34789308
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
[TBL] [Abstract][Full Text] [Related]
10. Clinical Trials Registration and Results Information Submission. Final rule.
National Institutes of Health, Department of Health and Human Services
Fed Regist; 2016 Sep; 81(183):64981-5157. PubMed ID: 27658315
[TBL] [Abstract][Full Text] [Related]
11. ClinicalTrials.gov reporting: strategies for success at an academic health center.
O'Reilly EK; Hassell NJ; Snyder DC; Natoli S; Liu I; Rimmler J; Amspacher V; Burnett BK; Parrish AB; Berglund JP; Stacy M
Clin Transl Sci; 2015 Feb; 8(1):48-51. PubMed ID: 25387802
[TBL] [Abstract][Full Text] [Related]
12. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial registration and reporting: a survey of academic organizations in the United States.
Mayo-Wilson E; Heyward J; Keyes A; Reynolds J; White S; Atri N; Alexander GC; Omar A; Ford DE;
BMC Med; 2018 May; 16(1):60. PubMed ID: 29716585
[TBL] [Abstract][Full Text] [Related]
14. Reporting Compliance and Factors Influencing Timeliness of Stroke-Related Trial Results on ClinicalTrials.gov.
Cwajna M; Hamouda AM; Kendall N; Ghozy S; Elder BD; Kallmes DF
Transl Stroke Res; 2024 Jun; ():. PubMed ID: 38831158
[TBL] [Abstract][Full Text] [Related]
15. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
16. FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study.
Marin Dos Santos DH; Atallah ÁN
PeerJ; 2015; 3():e1015. PubMed ID: 26131374
[TBL] [Abstract][Full Text] [Related]
17. An Institutional Program to Increase Compliance with Clinicaltrials.gov Requirements.
Kelly-Pumarol I; Andrews JE
Ther Innov Regul Sci; 2019 Mar; 53(2):190-192. PubMed ID: 29807449
[TBL] [Abstract][Full Text] [Related]
18. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
19. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
Prayle AP; Hurley MN; Smyth AR
BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
[TBL] [Abstract][Full Text] [Related]
20. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]